Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 2
1956 1
1957 2
1958 1
1959 5
1960 1
1961 2
1962 1
1963 9
1964 5
1965 4
1966 6
1967 4
1968 2
1969 5
1970 4
1971 2
1972 3
1973 3
1974 2
1975 4
1976 3
1977 4
1978 12
1979 9
1980 9
1981 7
1982 11
1983 5
1984 15
1985 10
1986 8
1987 17
1988 10
1989 11
1990 16
1991 18
1992 23
1993 17
1994 23
1995 24
1996 21
1997 24
1998 18
1999 28
2000 27
2001 23
2002 35
2003 37
2004 30
2005 46
2006 60
2007 49
2008 56
2009 63
2010 50
2011 52
2012 74
2013 60
2014 64
2015 60
2016 55
2017 59
2018 58
2019 46
2020 58
2021 56
2022 19
Text availability
Article attribute
Article type
Publication date

Search Results

1,422 results
Results by year
Filters applied: . Clear all
Page 1
The role of phosphate in kidney disease.
Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D; ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group. Vervloet MG, et al. Among authors: johansson l. Nat Rev Nephrol. 2017 Jan;13(1):27-38. doi: 10.1038/nrneph.2016.164. Epub 2016 Nov 21. Nat Rev Nephrol. 2017. PMID: 27867189 Review.
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
Stein RM, Kang HJ, McCorvy JD, Glatfelter GC, Jones AJ, Che T, Slocum S, Huang XP, Savych O, Moroz YS, Stauch B, Johansson LC, Cherezov V, Kenakin T, Irwin JJ, Shoichet BK, Roth BL, Dubocovich ML. Stein RM, et al. Among authors: johansson lc. Nature. 2020 Mar;579(7800):609-614. doi: 10.1038/s41586-020-2027-0. Epub 2020 Feb 10. Nature. 2020. PMID: 32040955 Free PMC article.
Structural basis of ligand recognition at the human MT1 melatonin receptor.
Stauch B, Johansson LC, McCorvy JD, Patel N, Han GW, Huang XP, Gati C, Batyuk A, Slocum ST, Ishchenko A, Brehm W, White TA, Michaelian N, Madsen C, Zhu L, Grant TD, Grandner JM, Shiriaeva A, Olsen RHJ, Tribo AR, Yous S, Stevens RC, Weierstall U, Katritch V, Roth BL, Liu W, Cherezov V. Stauch B, et al. Among authors: johansson lc. Nature. 2019 May;569(7755):284-288. doi: 10.1038/s41586-019-1141-3. Epub 2019 Apr 24. Nature. 2019. PMID: 31019306 Free PMC article.
Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial.
Rosqvist F, Kullberg J, Ståhlman M, Cedernaes J, Heurling K, Johansson HE, Iggman D, Wilking H, Larsson A, Eriksson O, Johansson L, Straniero S, Rudling M, Antoni G, Lubberink M, Orho-Melander M, Borén J, Ahlström H, Risérus U. Rosqvist F, et al. Among authors: johansson l. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6207-6219. doi: 10.1210/jc.2019-00160. J Clin Endocrinol Metab. 2019. PMID: 31369090 Free PMC article. Clinical Trial.
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnström M, Moris L, Miliotis T, Forsberg GB, Risérus U, Lind L, Oscarsson J. Eriksson JW, et al. Among authors: johansson l. Diabetologia. 2018 Sep;61(9):1923-1934. doi: 10.1007/s00125-018-4675-2. Epub 2018 Jul 3. Diabetologia. 2018. PMID: 29971527 Free PMC article. Clinical Trial.
Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism.
Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, Chmielewski M, Cordeiro AC, Espinosa-Cuevas A, Fiaccadori E, Guebre-Egziabher F, Hand RK, Hung AM, Ikizler TA, Johansson LR, Kalantar-Zadeh K, Karupaiah T, Lindholm B, Marckmann P, Mafra D, Parekh RS, Park J, Russo S, Saxena A, Sezer S, Teta D, Ter Wee PM, Verseput C, Wang AYM, Xu H, Lu Y, Molnar MZ, Kovesdy CP. Carrero JJ, et al. Among authors: johansson lr. J Ren Nutr. 2018 Nov;28(6):380-392. doi: 10.1053/j.jrn.2018.08.006. J Ren Nutr. 2018. PMID: 30348259
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.
Bolinder J, Ljunggren Ö, Johansson L, Wilding J, Langkilde AM, Sjöström CD, Sugg J, Parikh S. Bolinder J, et al. Among authors: johansson l. Diabetes Obes Metab. 2014 Feb;16(2):159-69. doi: 10.1111/dom.12189. Epub 2013 Aug 29. Diabetes Obes Metab. 2014. PMID: 23906445 Clinical Trial.
1,422 results